A randomized, double-blind, 3-way crossover, analog classroom study of SHP465 mixed amphetamine salts extended-release in adolescents with ADHD-Reference-Cited by-同舟云学术

A randomized, double-blind, 3-way crossover, analog classroom study of SHP465 mixed amphetamine salts extended-release in adolescents with ADHD

Published:2019-02-18 Issue:3 Volume:131 Page:212-224
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Wigal Sharon¹,Lopez Frank²,Frick Glen³,Yan Brian⁴,Robertson Brigitte⁵,Madhoo Manisha⁶

Affiliation:

1. AVIDA Inc., Newport Beach, CA, USA

2. Children’s Developmental Center, Winter Park, FL, USA

3. Formerly of Global Clinical Development, Shire, a member of the Takeda group of companies, Lexington, MA, USA

4. Biostatistics, Shire, a member of the Takeda group of companies, Lexington, MA, USA

5. Global Clinical Development, Shire, a member of the Takeda group of companies, Lexington, MA, USA

6. Global Medical Affairs, Shire, a member of the Takeda group of companies, Lexington, MA, USA

Funder

Shire Development LLC

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://tandfonline.com/doi/pdf/10.1080/00325481.2019.1574402

Reference37 articles.

1. Concerta® (methylphenidate hydrochloride extended-release tablets). Full Prescribing Information [package insert]. Titusville (NJ): McNeil Pediatrics; 2008.

2. Adderall XR® (mixed salts of a single-entity amphetamine product). Full Prescribing Information [package insert]. Lexington (MA): Shire US Inc. 2017.

3. Vyvanse® (lisdexamfetamine dimesylate). Full Prescribing Information [package insert]. Lexington (MA): Shire US Inc. 2017.

4. Lisdexamfetamine Dimesylate and Mixed Amphetamine Salts Extended-Release in Children with ADHD: A Double-Blind, Placebo-Controlled, Crossover Analog Classroom Study

5. Analog Classroom Assessment of a Once-Daily Mixed Amphetamine Formulation, SLI381 (ADDERALL XR), in Children With ADHD

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of amphetamine extended release once-daily options for the management of attention-deficit hyperactivity disorder;Expert Review of Neurotherapeutics;2024-02-23

2. Stimulants;Child and Adolescent Psychiatric Clinics of North America;2022-07

3. Sleep as an outcome measure in ADHD randomized controlled trials: A scoping review;Sleep Medicine Reviews;2022-06

4. Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension;Journal of Child and Adolescent Psychopharmacology;2021-11-01

5. Effect of a Multilayer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial Followed by a 6-Month Open-Label Follow-Up;Journal of Child and Adolescent Psychopharmacology;2021-11-01